GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samil Pharmaceutical Co Ltd (XKRX:000520) » Definitions » Shiller PE Ratio

Samil Pharmaceutical Co (XKRX:000520) Shiller PE Ratio : (As of Jun. 04, 2024)


View and export this data going back to 1985. Start your Free Trial

What is Samil Pharmaceutical Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Samil Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Samil Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samil Pharmaceutical Co Shiller PE Ratio Chart

Samil Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Samil Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Samil Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Samil Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samil Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samil Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Samil Pharmaceutical Co's Shiller PE Ratio falls into.



Samil Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Samil Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Samil Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-118/118.8477*118.8477
=-118.000

Current CPI (Mar. 2024) = 118.8477.

Samil Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -323.725 99.353 -387.245
201409 -260.034 99.608 -310.261
201412 -335.585 99.098 -402.465
201503 49.635 99.720 59.156
201506 15.813 100.050 18.784
201509 14.056 100.110 16.687
201512 -28.551 100.220 -33.858
201603 46.560 100.560 55.027
201606 -19.766 100.790 -23.307
201609 28.112 101.460 32.930
201612 21.523 101.560 25.187
201703 51.831 102.850 59.893
201706 -24.159 102.610 -27.982
201709 -172.624 103.490 -198.241
201712 36.018 102.990 41.564
201803 -79.943 104.100 -91.268
201806 -185.909 104.130 -212.185
201809 -209.545 105.650 -235.721
201812 -245.000 104.350 -279.039
201903 87.273 104.490 99.265
201906 75.000 104.880 84.988
201909 -33.182 105.200 -37.487
201912 -70.455 105.120 -79.656
202003 135.000 105.540 152.022
202006 11.818 104.870 13.393
202009 -17.727 106.200 -19.838
202012 -39.592 105.765 -44.489
202103 22.273 107.357 24.657
202106 -83.636 107.579 -92.397
202109 -120.000 108.759 -131.131
202112 -225.455 109.676 -244.308
202203 24.546 111.806 26.092
202206 -18.182 114.083 -18.941
202209 -138.182 114.831 -143.015
202212 132.727 115.200 136.929
202303 55.000 116.550 56.084
202306 35.000 117.140 35.510
202309 -46.000 119.111 -45.898
202312 61.821 118.848 61.821
202403 -118.000 118.848 -118.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Samil Pharmaceutical Co  (XKRX:000520) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Samil Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Samil Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Samil Pharmaceutical Co (XKRX:000520) Business Description

Traded in Other Exchanges
N/A
Address
990-1, Bangbae-dong, Seocho-Gu, Seoul, KOR, 137-060
Samil Pharmaceutical Co Ltd is engaged in manufacturing and distribution of pharmaceutical products and medicines in South Korea. Its products portfolio consists of gastrointestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives.

Samil Pharmaceutical Co (XKRX:000520) Headlines

No Headlines